Adam joins Sitryx with deep expertise in biotechnology capital markets, M&A and business development and strategic leadership Oxford, UK and Boston, MA – 8 September 2025 – Sitryx Therapeutics (“the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback